Biological Muscle as the Performance Benchmark
Before designing artificial muscles, engineers must understand the extraordinary performance of the benchmark: human skeletal muscle.
Skeletal muscle is a hierarchical, fibre-based actuator. At the nanoscale, actin and myosin protein filaments slide past each other in a ratchet-like mechanism powered by ATP hydrolysis. These sarcomeres (~2 µm long) are arranged in series and parallel to form myofibrils, then muscle fibres, then fascicles, and finally a complete muscle belly enclosed in connective tissue.
Key performance metrics of skeletal muscle:
- Isometric stress: ~0.1–0.3 MPa (force per unit cross-section)
- Strain: ~20–40% contraction from rest length
- Specific power: ~50–200 W/kg (muscle mass) during fast contractions
- Efficiency: 20–35% (thermodynamic; much of the rest is heat)
- Bandwidth: up to ~100 Hz for fast-twitch fibres during brief tetanus
- Self-healing: minor damage repaired by satellite cells within days to weeks
- Proprioception: muscle spindles and Golgi tendon organs provide intrinsic length and force sensing
- Scalability: same basic mechanism operates in organisms from insects to blue whales
No single artificial actuator matches all these properties simultaneously. Most exceed biological muscle in specific stress (SMA: 200 MPa vs 0.3 MPa) but fall short in strain, efficiency, self-healing, and integrated sensing. The artificial muscle challenge is fundamentally one of material integration and multi-functional design.
Artificial Muscle Technologies vs Biological Muscle
| Technology | Stress (MPa) | Strain (%) | Efficiency (%) | Speed | Maturity |
|---|---|---|---|---|---|
| Biological muscle | 0.1–0.3 | 20–40 | 20–35 | High (to 100 Hz) | N/A — the benchmark |
| Hydraulic actuator | ~10–35 | > 50 (linear) | 70–90 | Very high (> 100 Hz) | Very high |
| Pneumatic PAM (McKibben) | ~0.1–0.7 | 20–30 | 40–60 | Medium (1–10 Hz) | High |
| SMA (NiTinol) | ~100–200 | 4–8 | < 5 | Low (< 2 Hz) | Medium |
| Dielectric Elastomer | ~0.1–1 | 30–300 (area) | 60–80 | High (> 100 Hz) | Medium |
| IPMC | ~0.1–0.5 | > 90° bend | < 5 | Low (< 10 Hz) | Low–medium |
| Twisted coil (TCP) | ~10–60 | 10–50 | 25–35 | Low–medium | Low–medium |
| Hydrogel | ~0.001–0.1 | 100–1000 (volumetric) | < 5 | Very slow | Low |
Biomimetic Actuation Strategies
Biological organisms achieve superior performance not only through better actuator materials but through architectural strategies that engineers are now applying to robotic systems:
1. Agonist-Antagonist Pairs Biological joints are driven by opposing muscle groups: the bicep flexes the elbow, the tricep extends it. No single muscle can push; it can only pull. Robotic joints implementing this architecture use two actuators (motors, PAMs, or cables) in opposition. The key advantage is variable stiffness: by co-contracting both actuators, the joint becomes stiffer; by modulating the balance, position changes. This is the principle behind the Variable Stiffness Actuator (VSA), used in the DLR Hand Arm System and Pisa/IIT SoftHand.
2. Distributed Actuation Biological muscle fibres are recruited in groups (motor units) in response to load, enabling smooth force gradation and local fatigue management. Distributed cable-driven or PAM-driven robots mimic this by actuating a continuum body with many inputs, enabling rich shape spaces from redundant actuation.
3. Tendon Routing and Cable-Driven Hands The human hand has 27 bones but only 6 intrinsic muscles in the palm and 18 forearm muscles connected by long tendons. Cable-driven robotic hands (Shadow Dexterous Hand, Allegro Hand) replicate this architecture: motors located in a remote forearm unit route Bowden cables to finger joints. Benefits include remote mass distribution, compliance via cable elasticity, and dexterity from underactuation.
4. Variable Stiffness Actuators (VSA) VSAs modulate mechanical impedance during task execution — stiff during precision positioning, compliant during impact or human contact. Designs include: dual-motor with spring coupling (qbMove), cam-based spring preload (VS-Joint), and non-linear spring mechanisms (AMASC).
Wearable Actuators: Exoskeletons and Exosuits
Wearable robotic actuators form the foundation of exoskeletons and exosuits — devices worn on the human body to augment, assist, or rehabilitate movement. Two broad paradigms have emerged:
Rigid Exoskeletons Rigid exoskeletons (Ekso Bionics EksoGT, ReWalk Robotics P6, Cyberdyne HAL) use rigid aluminium or carbon-fibre frames aligned to the user's skeletal segments, with motorised joints (DC servo or hydraulic) at hip, knee, and ankle. They can deliver large joint torques (> 100 N·m) and are used for spinal cord injury rehabilitation, industrial worker assistance, and military load augmentation.
Challenges include: precise kinematic alignment (human joint axes shift during movement, unlike fixed robot joints), donning/doffing complexity, mass (8–25 kg), and high cost (USD 70 000–150 000).
Soft Exosuits The Harvard Biodesign Lab and collaborators pioneered soft exosuits: lightweight (~1 kg) garments using Bowden cable transmissions driven by actuators mounted at the waist or back. Cables route along the outer surface of limbs and attach at anchor points on the foot, shank, and thigh. Biomechanically, the suit augments ankle push-off and hip flexion at the appropriate gait phases, reducing metabolic cost of walking by 7–23% in healthy subjects and 15–30% in post-stroke patients.
Assistive hand orthoses use pneumatic soft actuators (glove-mounted PneuNet or cable-driven fingers) to assist grasping in spinal cord injury and stroke patients, providing controlled finger extension and flexion during rehabilitation.
Rigid Exoskeleton vs Soft Exosuit
Rigid Exoskeleton
- Mass: 8–25 kg — significant metabolic penalty to carry the device itself
- Force/torque: very high (> 100 N·m at joints) — enables full body weight support
- Compliance: low — rigid structure can resist natural joint motion if misaligned
- Kinematic alignment: critical — misalignment causes painful hyperstaticity and skin pressure
- Donning time: 5–20 minutes with carer assistance
- Cost: USD 70 000–150 000 for medical-grade devices
- Use case: complete lower-limb paralysis, heavy industrial load carrying
Soft Exosuit
- Mass: 0.5–3 kg — low metabolic overhead; garment-like form factor
- Force/torque: moderate (10–50 N·m) — assists gait rather than replacing muscle
- Compliance: high — cable transmissions and fabric adapt to natural limb motion
- Kinematic alignment: not required — cables transmit force along limb surface
- Donning time: 1–5 minutes independently for trained users
- Cost: USD 5 000–50 000 — lower fabrication complexity
- Use case: gait assistance in stroke, CP, aging; metabolic augmentation in healthy users